Register
Log in
Contact us
English
Deutsch
Français
English UK
Español
简体中文
한국어
Products
GMP Cytokines
RUO Cytokines
Cytokine Packages
Animal-Free Cytokines
Growth Factors & Cytokines
Chemokines
Neurotrophins
Proteases
Other Proteins
Antibodies
Antigen Affinity Purified Polyclonal Antibodies
Biotinylated Polyclonal Antibodies
Monoclonal Antibodies
Control Antibodies
ELISA Kits
ABTS ELISA Kits
TMB ELISA Kits
Research Areas
AIDS/HIV
Allergy
Angiogenesis/Cardiovascular
Apoptosis
Bone, Skeletal, Cartilage
Cancer
Cell Culture
CAR T Cell
COVID-19
Chemotaxis
Diabetes/Weight Regulation
FGF Superfamily
Immune System
Inflammation
Lipid Metabolism
Neurobiology
Organoids
Proliferation
Receptors
Stem Cells & Differentiation
TGF-β Superfamily
TNF Superfamily
Transplantation
Wound Healing
New Products
Quality
Quality Policy
GMP
RUO
Antibodies and ELISA Kits
Resources and Support
Literature
References
webinars
WHO Unit Chart
Technical Investigation Forms
Protocols
FAQs
Troubleshooting Guides
Videos
Choosing a Product Line
About
Executive Team
Diversity, Equity and Inclusion
Our Story
Who We Are
Careers
What We Believe
Company Profile
Testimonials
Events
CoA Search
Quick Order
Cart (0)
Menu
Toggle navigation
Cart (0)
GMP Cytokines
RUO Cytokines
Cytokine Packages
Animal-Free Cytokines
Growth Factors & Cytokines
Chemokines
Neurotrophins
Proteases
Other Proteins
Antibodies
Antigen Affinity Purified Polyclonal Antibodies
Biotinylated Polyclonal Antibodies
Monoclonal Antibodies
Control Antibodies
ELISA Kits
ABTS ELISA Kits
TMB ELISA Kits
Research Areas
AIDS/HIV
Allergy
Angiogenesis/Cardiovascular
Apoptosis
Bone, Skeletal, Cartilage
Cancer
Cell Culture
CAR T Cell
COVID-19
Chemotaxis
Diabetes/Weight Regulation
FGF Superfamily
Immune System
Inflammation
Lipid Metabolism
Neurobiology
Organoids
Proliferation
Receptors
Stem Cells & Differentiation
TGF-β Superfamily
TNF Superfamily
Transplantation
Wound Healing
New Products
Quality
Resources and Support
About
Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to
ThermoFisher.com
.
Resources & Support
References
First Author:
Title:
Date:
Catalog Number:
PubMed ID:
Cross Reactivity:
Journal:
Application:
First Author
Di Pilato, M
Title
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.
Citation
Cell; 2021 Aug 19; 184(17) pg4512-4530.e22
PubMed ID
34343496
Show Usages
Product Cited
Cross-Reactivity
Applications
250-28
Mouse
in vitro
First Author
Jacob, N
Title
Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes
Citation
Scientific reports; 2020 Nov 5; 10(1) pg19120
PubMed ID
33154424
Show Usages
Product Cited
Cross-Reactivity
Applications
250-28
Mouse
in vitro
First Author
Yagawa, Y
Title
Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy.
Citation
Scientific Reports; 2017 Nov 22; 7(1) pg15996
PubMed ID
29167448
Show Usages
Product Cited
Cross-Reactivity
Applications
300-44
Human
in vitro
300-34
Human
in vitro
300-41
Human
in vitro
200-08
Human
in vitro
250-10
Mouse
in vitro
250-09
Mouse
in vitro
250-32
Mouse
in vitro
250-07
Mouse
in vitro
250-06
Mouse
in vitro
250-08
Mouse
in vitro
250-14
Mouse
in vitro
250-12
Mouse
in vitro
250-01
Mouse
in vitro
250-04
Mouse
in vitro
250-27B
Mouse
in vitro
250-27
Mouse
in vitro
250-13
Mouse
in vitro
250-23
Mouse
in vitro
250-22
Mouse
in vitro
250-26
Mouse
in vitro
250-30
Mouse
in vitro
250-11
Mouse
in vitro
250-15
Mouse
in vitro
250-39
Mouse
in vitro
250-17
Mouse
in vitro
250-18
Mouse
in vitro
250-16
Mouse
in vitro
250-29
Mouse
in vitro
250-20B
Mouse
in vitro
250-37
Mouse
in vitro
250-28
Mouse
in vitro
First Author
Singh, K
Title
Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities.
Citation
Scientific Reports; 2017 Jun 27; 7(1) pg4267
PubMed ID
28655871
Show Usages
Product Cited
Cross-Reactivity
Applications
300-34
Human
in vitro
300-11
Human
in vitro
300-15
Human
in vitro
300-29B
Human
in vitro
300-46
Human
in vitro
300-48
Human
in vitro
300-54
Human
in vitro
300-08
Human
in vitro
300-28A
Human
in vitro
300-43
Human
in vitro
300-45
Human
in vitro
300-31
Human
in vitro
300-36A
Human
in vitro
300-14
Human
in vitro
300-39
Human
in vitro
300-55
Human
in vitro
300-16
Human
in vitro
300-28B
Human
in vitro
300-22
Human
in vitro
300-44
Human
in vitro
300-33
Human
in vitro
300-26
Human
in vitro
300-38
Human
in vitro
300-57
Human
in vitro
300-24
Human
in vitro
300-40
Human
in vitro
300-41
Human
in vitro
300-30
Human
in vitro
300-12
Human
in vitro
300-50
Human
in vitro
300-47
Human
in vitro
300-29A
Human
in vitro
300-35
Human
in vitro
300-17
Human
in vitro
300-09
Human
in vitro
300-56
Human
in vitro
300-04
Human
in vitro
300-21
Human
in vitro
250-01
Mouse
Binding Assay
250-04
Mouse
Binding Assay
250-06
Mouse
Binding Assay
250-07
Mouse
Binding Assay
250-10
Mouse
Binding Assay
250-11
Mouse
Binding Assay
250-12
Mouse
Binding Assay
250-13
Mouse
Binding Assay
250-15
Mouse
Binding Assay
250-16
Mouse
Binding Assay
250-17
Mouse
Binding Assay
250-18
Mouse
Binding Assay
250-20A
Mouse
Binding Assay
250-20B
Mouse
Binding Assay
250-22
Mouse
Binding Assay
250-23
Mouse
Binding Assay
250-24
Mouse
Binding Assay
250-26
Mouse
Binding Assay
250-27
Mouse
Binding Assay
250-27B
Mouse
Binding Assay
250-28
Mouse
Binding Assay
250-29
Mouse
Binding Assay
250-30
Mouse
Binding Assay
250-32
Mouse
Binding Assay
250-36
Mouse
Binding Assay
250-37
Mouse
Binding Assay
250-39
Mouse
Binding Assay
First Author
Di Castro, M A
Title
The chemokine CXCL16 modulates neurotransmitter release in hippocampal CA1 area.
Citation
Scientific Reports; 2016 Oct 10; 6 pg34633
PubMed ID
27721466
Show Usages
Product Cited
Cross-Reactivity
Applications
250-28
Mouse
in vitro
First Author
Grimaldi, A
Title
KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Citation
Cell death & disease; 2016 Apr 7; 7 pge2174
PubMed ID
27054329
Show Usages
Product Cited
Cross-Reactivity
Applications
250-28
Mouse
in vitro
300-28A
Mouse
in vitro
First Author
Gwyer Findlay, E
Title
IL-27 receptor signaling regulates CD4+ T cell chemotactic responses during infection.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2013 May 1; 190(9) pg4553-61
PubMed ID
23536628
Show Usages
Product Cited
Cross-Reactivity
Applications
250-32
Mouse
in vitro
250-27
Mouse
in vitro
250-13
Mouse
in vitro
250-18
Mouse
in vitro
250-20A
Mouse
in vitro
250-28
Mouse
in vitro
250-07
Mouse
in vitro
250-16
Mouse
in vitro
First Author
Zhang, F
Title
Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2013 Feb 1; 190(3) pg1017-25
PubMed ID
23267022
Show Usages
Product Cited
Cross-Reactivity
Applications
300-30
Mouse
in vitro
250-10
Mouse
in vitro
250-27
Mouse
in vitro
250-20A
Mouse
in vitro
250-28
Mouse
in vitro
250-07
Mouse
in vitro
250-27B
Mouse
in vitro
300-45
Mouse
in vitro
250-24
Mouse
in vitro
First Author
Ruocco, M G
Title
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.
Citation
The Journal of Clinical Investigation; 2012 Oct; 122(10) pg3718-30
PubMed ID
22945631
Show Usages
Product Cited
Cross-Reactivity
Applications
250-28
Mouse
in vitro
First Author
Chamberlain, G
Title
Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear.
Citation
PLoS ONE; 2011; 6(9) pge25663
PubMed ID
21980522
Show Usages
Product Cited
Cross-Reactivity
Applications
250-18
Mouse
in vitro
250-27
Mouse
in vitro
250-28
Mouse
in vitro
450-32
Mouse
in vitro
315-01A
Mouse
in vitro
300-45
Mouse
in vitro
showing 10 of 13
Show More
Quick Order: Upload CSV Instructions
Navigate to the CSV file of PeproTech products on your computer. Click on the file name to highlight it. Then, click "Open" in the dialog box. Items will load on the Quick Order form.
Coming Soon
This feature is coming soon.